Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CENPB DNA-binding domains containing 2, pseudogene (CENPBD2P) is a human pseudogene located on chromosome 19q13.43, as referenced by its Gene ID 65996[1][3][5]. It is classified as a pseudogene, meaning it resembles a known gene but is typically non-functional and does not produce a functional protein product[1][6]. CENPBD2P has also been referred to by aliases such as RPL23AP79 and CENPBD1P1, and is associated with ribosomal protein L23a pseudogene 79 identifiers in some databases[6]. As a pseudogene, CENPBD2P does not encode a receptor, enzyme, transporter, or other actionable therapeutic target, and is not known to be involved in any specific biological functions or disease roles[1][6]. No drugs, mechanisms of action, biomarkers, or safety concerns are associated with this pseudogene. This gene should not be confused with functional genes related to centromere protein B (CENP-B), a DNA-binding protein critical for centromere structure and function[7][9]. The presence of "pseudogene" in its name and classification indicates it is not therapeutically actionable or a direct molecular target in drug discovery. Key clarifications: - CENPBD2P is a **pseudogene** (not a protein-coding gene or druggable target)[1][6]. - There is **no evidence** that it serves as a therapeutic target or has a defined role in disease or normal biological processes[1][6]. - If your intent was to find information about the functional protein CENP-B (centromere protein B), you should instead refer to the CENPB gene, which is functionally distinct from its pseudogene counterparts[7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CENPB DNA-binding domains containing 2, pseudogene (CENPBD2P).